Clinical Evaluation of the Adaptilens Accommodating IOL
NCT: NCT07607860 · NOT_YET_RECRUITING
Brief Summary
The goal of this feasibility study is to learn more about the performance of the intraocular lens device, if the device is safe for use and what the best surgical techniques are for implanting the product in patients who require correction of aphakia following phacoemulsification extraction of a senile cataract. The main questions it aims to answer are: * Will the patient have any related complications? * Will a patient's vision improve after surgery? Researchers will compare the eye treated with the investigational product with the eye treated with another product to see if there are any differences in vision and safety. * Participants will be asked to attend all scheduled visits for the study, approximately 11 visits in total over 3 years. * During these visits the participants will be asked about their medical history, have testing and measurements taken, and one visit that is the scheduled surgery. The participants will be asked to use eye drops that have been prescribed by the doctor performing the surgery.
Frequently Asked Questions
What is Clinical Evaluation of the Adaptilens Accommodating IOL?
Clinical Evaluation of the Adaptilens Accommodating IOL is a clinical trial registered under NCT07607860. Current status: NOT_YET_RECRUITING.
What is the status of NCT07607860?
The current status of NCT07607860 (Clinical Evaluation of the Adaptilens Accommodating IOL) is: NOT_YET_RECRUITING.
When did Clinical Evaluation of the Adaptilens Accommodating IOL start?
Clinical Evaluation of the Adaptilens Accommodating IOL started on 2026-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.